Maxillent

About

Maxillent develops the iRaise sinus lift system, which transforms the sinus lift into a simple, minimally invasive procedure. iRaise offers simplicity and ease of use to the dentist and a cost-effective solution for dental implant manufacturers. The company's first human implantations were achieved within 11 months of the commencement of operations, and sales were achieved within three years. Sales are ongoing in several countries including France, Italy, and China. Maxillent also develops prosthetics, surgical instruments, and bone graft materials. Maxillent is a portfolio company of Rainbow Medical Investments.

Facts

Team (3)

News mentions (1)

1. Jun 3, 2013 — www.dentistryiq.com: Article